59392-49-3

Usage

Uses

Used in Pharmaceutical Industry:
Gastric Inhibitory Polypeptide (Porcine) is used as a therapeutic agent for the treatment of diabetes and obesity. Its ability to regulate insulin secretion, glucose metabolism, and gastric emptying makes it a promising candidate for managing blood glucose levels and promoting weight loss.
Used in Research Applications:
GIP is used as a research tool for studying the mechanisms of insulin secretion, glucose metabolism, and gastrointestinal functions. It helps researchers understand the role of GIP in the regulation of appetite, energy balance, and glucose homeostasis, which can lead to the development of new treatments for diabetes, obesity, and other metabolic disorders.
Used in Nutritional Supplements:
Gastric Inhibitory Polypeptide (Porcine) can be used as an ingredient in nutritional supplements to support healthy glucose metabolism and weight management. Its ability to stimulate insulin release and slow gastric emptying may help individuals maintain healthy blood sugar levels and promote satiety, leading to better weight control.
Used in Drug Development:
GIP is used in the development of new drugs targeting diabetes and obesity treatment. Researchers are exploring the potential of GIP-based therapies, such as GIP receptor agonists or antagonists, to modulate insulin secretion and glucose metabolism, offering novel treatment options for patients with metabolic disorders.